Follow-up care for cancer: Making the benefits equal the cost

David Schwartz, Kevin Billingsley, Kent Wallner

    Research output: Contribution to journalArticle

    14 Scopus citations


    Posttreatment follow-up is a staple of oncologic practice. Clinicians have traditionally presumed that close surveillance improves clinical outcome. However, new evidence reveals that frequent, procedure-intensive follow-up may provide no more significant benefit to patients than simpler approaches. Several recent consensus recommendations from major oncology organizations support this theory. Published surveys of clinician and institutional follow-up policies reveal significant variations in practice, with many providers continuing to use costly, unproven regimens. This review highlights current data on follow-up care for three common cancers - breast, colorectal, and prostate. These data suggest an acute need for changes leading to more rational, consistent, and efficient follow-up practices.

    Original languageEnglish (US)
    Pages (from-to)1493-1501
    Number of pages9
    Issue number10
    StatePublished - Dec 1 2000


    ASJC Scopus subject areas

    • Oncology
    • Cancer Research

    Cite this

    Schwartz, D., Billingsley, K., & Wallner, K. (2000). Follow-up care for cancer: Making the benefits equal the cost. ONCOLOGY, 14(10), 1493-1501.